Introduction
flowchart TD
MRI["MRI"] -->|"associated with"| Neurodegenerative_Disorders["Neurodegenerative Disorders"]
MRI["MRI"] -->|"biomarker for"| Neurodegenerative_Disorders["Neurodegenerative Disorders"]
MRI["MRI"] -->|"associated with"| Huntington_S_Disease["Huntington'S Disease"]
MRI["MRI"] -->|"associated with"| Parkinson_S_Disease["Parkinson'S Disease"]
MRI["MRI"] -->|"associated with"| Alzheimer_S_Disease["Alzheimer'S Disease"]
MRI["MRI"] -->|"associated with"| Amyotrophic_Lateral_Sclerosis["Amyotrophic Lateral Sclerosis"]
Mri["Mri"] -->|"biomarker for"| Drug_Resistant_Epilepsy["Drug-Resistant Epilepsy"]
MRI["MRI"] -->|"regulates"| MOLECULAR_IMAGING["MOLECULAR_IMAGING"]
MRI["MRI"] -->|"biomarker for"| mild_cognitive_impairment["mild cognitive impairment"]
MRI["MRI"] -->|"biomarker for"| Alzheimer_s_disease["Alzheimer's disease"]
Machine_Learning["Machine Learning"] -->|"modulates"| MRI["MRI"]
style MRI fill:#4fc3f7,stroke:#333,color:#000
Magnetic Resonance Imaging (MRI) is a cornerstone of neuroimaging for neurodegenerative diseases, providing detailed anatomical, structural, and increasingly functional information about the living brain. MRI is essential for diagnosing [Alzheimer's disease](/diseases/alzheimers-disease), [Parkinson's disease](/diseases/parkinsons-disease), and [atypical parkinsonian syndromes](/diseases/atypical-parkinsonism), as well as for monitoring disease progression and evaluating therapeutic responses["@scheltens2020"][@haller2013].
...
Introduction
Mermaid diagram (expand to render)
Magnetic Resonance Imaging (MRI) is a cornerstone of neuroimaging for neurodegenerative diseases, providing detailed anatomical, structural, and increasingly functional information about the living brain. MRI is essential for diagnosing [Alzheimer's disease](/diseases/alzheimers-disease), [Parkinson's disease](/diseases/parkinsons-disease), and [atypical parkinsonian syndromes](/diseases/atypical-parkinsonism), as well as for monitoring disease progression and evaluating therapeutic responses["@scheltens2020"][@haller2013].
MRI Techniques in Neurodegeneration
Structural MRI The most commonly used technique, providing detailed anatomy:
T1-Weighted Imaging
Gray matter assessment : Hippocampal atrophy, cortical thinningWhite matter evaluation : Lesion detection, tract integrityVolumetric analysis : Regional brain volume measurementsClinical use : AD diagnosis, disease stagingT2-Weighted Imaging
Fluid-attenuated inversion recovery (FLAIR) : White matter hyperintensitiesT2 hyperintensities : Demyelination, gliosis, edemaClinical utility : Vascular changes, white matter diseaseSusceptibility-Weighted Imaging (SWI)
Iron deposition : Quantification of brain iron accumulationMicrohemorrhages : Cerebral microbleed detectionCalcification : Basal ganglia and other calcificationsUtility in : [NBIA](/diseases/nbia), [Parkinson's disease](/diseases/parkinsons-disease), [MSA](/diseases/multiple-system-atrophy)Diffusion MRI Measures water molecule motion, sensitive to microstructural changes:
Diffusion Tensor Imaging (DTI)
Fractional anisotropy (FA) : White matter integrityMean diffusivity (MD) : Overall diffusion magnitudeTractography : White matter tract reconstructionClinical applications :[Alzheimer's disease](/diseases/alzheimers-disease): Disruption of white matter tracts
[Parkinson's disease](/diseases/parkinsons-disease): Nigrostriatal pathway changes](/proteins/parkin)
[FTD](/diseases/behavioral-variant-ftd): Frontotemporal tract involvement
Advanced Diffusion Techniques | Technique | Information Gained | Clinical Application |
Functional MRI (fMRI) Measures blood oxygen level-dependent (BOLD) signal:
Resting-State fMRI
Default mode network : Functional connectivity changesDisease-specific patterns : Network breakdown in AD, PDPresymptomatic detection : Connectivity changes before atrophyTask-Based fMRI
Cognitive activation : Memory, executive function testingMotor activation : Finger tapping, gait paradigmsClinical research : Treatment effects on brain activityPerfusion MRI Measures cerebral blood flow:
Arterial Spin Labeling (ASL)
Non-contrast : No radiation, repeatableCerebral blood flow : Quantitative measurementsApplications : [CBS](/diseases/corticobasal-syndrome), [PSP](/diseases/steele-richardson-olszewski-syndrome), dementia subtypesMagnetic Resonance Spectroscopy (MRS) Measures metabolite concentrations:
| Metabolite | Significance |
MRS applications in neurodegeneration[@kantarci2014]:
Alzheimer's : Reduced NAA, elevated myo-inositolParkinson's : NAA changes in substantia nigraDementia : Metabolic profiling for differential diagnosisDisease-Specific MRI Findings
Alzheimer's Disease
Structural Findings
Hippocampal atrophy : Most sensitive early markerEntorhinal cortex thinning : Precedes hippocampal changesPosterior cingulate : Early hypometabolismCortical thinning : Temporal, parietal, frontal regionsVentricular enlargement : Secondary to parenchymal lossFunctional Findings
Default mode network disruption : Early functional disconnectivityPosterior cingulate hypoperfusion : Characteristic patternReduced hippocampal connectivity : Memory network dysfunctionParkinson's Disease
Structural Findings
Substantia nigra pars compacta : Loss of neuromelanin signalRed nucleus changes : Related to akinesiaPontine and cerebellar changes : In parkinsonian variantsLevodopa-induced changes : Long-term treatment effectsAdvanced MRI Findings
Neuromelanin-sensitive MRI : Loss of signal in substantia nigraIron-sensitive imaging (R2*, SWI) : Increased iron depositionDiffusion changes : In substantia nigra and striatumResting-state fMRI : Altered connectivity patterns[@gao2021]Atypical Parkinsonism
Progressive Supranuclear palsy (PSP)
Midbrain atrophy : "Hummingbird sign" on sagittal MRISuperior cerebellar peduncle : Signal changesRed nucleus : T2 hypointensityThird ventricle : DilatationMR parkinsonism index : Elevated in PSP vs. PDMultiple System Atrophy (MSA)
Brainstem/cerebellar atrophy : "Hot cross bun" signPutaminal atrophy : Hyperintense putaminal rimCerebellar atrophy : In MSA-C variantMiddle cerebellar peduncle : T2 hyperintensityCorticobasal Syndrome (CBS)
Asymmetric cortical atrophy : Frontoparietal regionsBasal ganglia : T2 changesCorpus callosum : Thinning, especially anteriorCentral atrophy : Brainstem involvementFrontotemporal Dementia | Variant | MRI Findings |
Vascular Dementia
White matter lesions : Confluent hyperintensities on FLAIRLacunes : Small subcortical infarctsMicrobleeds : Especially in amyloid angiopathyCortical infarcts : Territorial infarcts[@wardlaw2019]Dementia with Lewy Bodies
Relative preservation : Less hippocampal atrophy than ADOccipital hypoperfusion : Characteristic findingDorsal midbrain : Signal changesTemporal lobe : Less affected than ADQuantitative MRI Biomarkers
Volumetric Analysis | Region | AD | PD | PSP | MSA |
Atrophy Scoring
MTA scale (Medial Temporal Atrophy): 0-4 scale for hippocampal atrophyFazekas scale : White matter hyperintensity gradingKoedam score : Posterior atrophy scoringDiffusion Metrics
DTI in AD : Reduced FA in major white matter tractsDTI in PD : Changes in substantia nigra, white matterDTI in PSP : Superior cerebellar peduncle involvementClinical Applications
Diagnostic Workup
Initial evaluation : Rule out secondary causesDifferential diagnosis : AD vs. FTD vs. Lewy body dementiaAtypical parkinsonism : Distinguish MSA, PSP, CBS from PDProgression monitoring : Annual volumetric assessments
Research Applications
Clinical trials : Enrollment criteria, outcome measuresBiomarker development : Early detection, disease progressionTreatment monitoring : Disease-modifying therapy effectsNeuropathology correlation : In vivo pathology assessmentTechnical Considerations
MRI Field Strength | Field Strength | Advantages | Disadvantages |
Recommended Protocols
Neurodegeneration Protocol
T1-weighted (MPRAGE/IR-SPGR): 1mm isotropic
T2-weighted/FLAIR: 3mm slices
SWI: 1mm isotropic
DTI: 2mm isotropic, 30+ directions
Optional: ASL, MRS
Post-Processing Tools
FreeSurfer : Cortical parcellation, volumetric analysisFSL : Diffusion analysis, tractographyANTs : Image registration, normalizationSPM/FSL : Statistical parametric mappingBrainSuite : Surface-based analysisEmerging Techniques
Ultrahigh Field MRI (7T)
Increased signal : Higher SNR for detailed imagingImproved resolution : Sub-millimeter imaging possibleSusceptibility contrast : Enhanced SWI, QSMClinical research : Detecting early changesQuantitative Susceptibility Mapping (QSM)
Iron quantification : Direct measurement of brain ironMyelin imaging : Contrast from magnetic susceptibilityClinical potential : Parkinson's, MSA, NBIAMachine Learning in MRI
Automated analysis : Rapid image processingClassification : AD vs. normal vs. FTDPrediction : Converted MCI to ADRadiomics : Feature extraction for diagnosisLimitations
Technical Limitations
Motion artifact : Especially in dementia patientsPartial volume : Small structure resolutionScan time : Trade-offs between resolution and timeStandardization : Between-scanner variabilityClinical Limitations
Lack of specificity : Similar atrophy patternsLate detection : Changes occur after symptomsCost : MRI is expensive compared to CTAccess : Not all facilities have MRIReferences
[Scheltens et al., MRI biomarkers in Alzheimer's disease (2020)](https://doi.org/10.1016/j.jns.2020.116812)
[Haller et al., MRI of the aging brain (2013)](https://doi.org/10.1148/rg.333125032)
[Frisoni et al., Clinical use of structural MRI in Alzheimer disease (2010)](https://doi.org/10.1016/j.neurobiolaging.2010.01.003)
[Masdeu et al., Neuroimaging in neurodegenerative disorders (2016)](https://doi.org/10.1016/j.neurobiolaging.2015.10.025)
[Kantarci et al., MR spectroscopy in dementia (2014)](https://doi.org/10.1016/j.nic.2014.08.002)
[Wardlaw et al., Neuroimaging in vascular dementia (2019)](https://doi.org/10.1177/2391467319871815)
[Gao et al., Advanced MRI techniques in Parkinson's disease (2021)](https://doi.org/10.1159/000512480)
[Pyat et al., MRI in atypical parkinsonism (2022)](https://doi.org/10.1007/s00415-021-10927-6)
Related Pages
[MRI Findings in Corticobasal Syndrome](/diagnostics/mri-findings-in-corticobasal-syndrome)](/diagnostics)
[Diffusion Tensor Imaging](/diagnostics/diffusion-tensor-imaging-neurodegeneration)](/diagnostics)
[Magnetic Resonance Spectroscopy](/diagnostics/magnetic-resonance-spectroscopy-neurodegeneration)](/diagnostics)
[Neuromelanin MRI](/diagnostics/neuromelanin-magnetic-resonance-imaging)](/diagnostics)
[Susceptibility-Weighted Imaging](/diagnostics/susceptibility-weighted-imaging-swi)](/diagnostics)
[Alzheimer's Disease Diagnosis](/diseases/alzheimers-disease)
[Parkinson's Disease Diagnosis](/diseases/parkinsons-disease)](/proteins/parkin)
[Atypical Parkinsonism](/diseases/atypical-parkinsonism)
Show full description